About this document
Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns 2025 by umbriacoronadodouglas is a document available to read on EtoBox.
The document discusses antenatal diagnosis and treatment for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, emphasizing the importance of early identification and treatment of affected fetuses to prevent complications. It highlights the role of genetic testing and non-invasive prenatal testing (NIPT) in accurately diagnosing CAH and determining fetal sex, while also addressing the challenges and ethical considerations involved. Additionally, the document outlines the potential of pre
- Author
- umbriacoronadodouglas
- Language
- EN